144 related articles for article (PubMed ID: 9416855)
1. Increased phosphate content in complement component C3, fibrinogen, vitronectin, and other plasma proteins in systemic lupus erythematosus: covariation with platelet activation and possible association with thrombosis.
Ekdahl KN; Rönnblom L; Sturfelt G; Nilsson B
Arthritis Rheum; 1997 Dec; 40(12):2178-86. PubMed ID: 9416855
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation.
Ekdahl KN; Bengtsson AA; Andersson J; Elgue G; Rönnblom L; Sturfelt G; Nilsson B
Br J Haematol; 2004 Apr; 125(1):74-8. PubMed ID: 15015972
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of plasma proteins with emphasis on complement component C3.
Nilsson Ekdahl K; Nilsson B
Mol Immunol; 1999; 36(4-5):233-9. PubMed ID: 10403476
[TBL] [Abstract][Full Text] [Related]
4. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.
Ekdahl KN; Nilsson B
J Immunol; 1999 Jun; 162(12):7426-33. PubMed ID: 10358196
[TBL] [Abstract][Full Text] [Related]
5. Elevated beta-thromboglobulin and mean platelet volume levels may show persistent platelet activation in systemic lupus erythematosus patients.
Uyar S; Abanonu GB; Pehlevan SM; Karatoprak C; Mengüç MU; Daşkin A; Dolu S; Demirtunç R
Adv Clin Exp Med; 2018 Sep; 27(9):1279-1283. PubMed ID: 29790695
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of complement component C3 and C3 fragments by a human platelet protein kinase. Inhibition of factor I-mediated cleavage of C3b.
Ekdahl KN; Nilsson B
J Immunol; 1995 Jun; 154(12):6502-10. PubMed ID: 7539023
[TBL] [Abstract][Full Text] [Related]
7. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
[TBL] [Abstract][Full Text] [Related]
8. Impaired contraction of blood clots as a novel prothrombotic mechanism in systemic lupus erythematosus.
Le Minh G; Peshkova AD; Andrianova IA; Sibgatullin TB; Maksudova AN; Weisel JW; Litvinov RI
Clin Sci (Lond); 2018 Jan; 132(2):243-254. PubMed ID: 29295895
[TBL] [Abstract][Full Text] [Related]
9. In systemic lupus erythematosus anti-dsDNA antibodies can promote thrombosis through direct platelet activation.
Andrianova IA; Ponomareva AA; Mordakhanova ER; Le Minh G; Daminova AG; Nevzorova TA; Rauova L; Litvinov RI; Weisel JW
J Autoimmun; 2020 Feb; 107():102355. PubMed ID: 31732191
[TBL] [Abstract][Full Text] [Related]
10. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet GPIIb/IIIa binding to fibrinogen by serum factors: studies of circulating immune complexes and platelet antibodies in patients with hemophilia, immune thrombocytopenic purpura, human immunodeficiency virus-related immune thrombocytopenic purpura, and systemic lupus erythematosus.
Kamiyama M; Arkel YS; Chen K; Shido K
J Lab Clin Med; 1991 Mar; 117(3):209-17. PubMed ID: 2002277
[TBL] [Abstract][Full Text] [Related]
12. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
Ho A; Barr SG; Magder LS; Petri M
Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
[TBL] [Abstract][Full Text] [Related]
13. Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus.
Lood C; Tydén H; Gullstrand B; Nielsen CT; Heegaard NH; Linge P; Jönsen A; Hesselstrand R; Kahn R; Bengtsson AA
Rheumatology (Oxford); 2017 Mar; 56(3):408-416. PubMed ID: 28031442
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional down-regulation of the platelet ADP receptor P2Y(12) and clusterin in patients with systemic lupus erythematosus.
Wang L; Erling P; Bengtsson AA; Truedsson L; Sturfelt G; Erlinge D
J Thromb Haemost; 2004 Aug; 2(8):1436-42. PubMed ID: 15304052
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide production.
Ghiran IC; Zeidel ML; Shevkoplyas SS; Burns JM; Tsokos GC; Kyttaris VC
Arthritis Rheum; 2011 Feb; 63(2):503-12. PubMed ID: 21280005
[TBL] [Abstract][Full Text] [Related]
16. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
17. The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus.
Troldborg A; Jensen L; Deleuran B; Stengaard-Pedersen K; Thiel S; Jensenius JC
Front Immunol; 2018; 9():581. PubMed ID: 29632534
[TBL] [Abstract][Full Text] [Related]
18. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
Perrin LH; Lambert PH; Miescher PA
J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
[TBL] [Abstract][Full Text] [Related]
19. Expression of fibrinogen receptors on platelets of uremic patients is correlated with the content of GPIIb and plasma level of creatinine.
Walkowiak B; Pawlowska Z; Michalak E; Cierniewski CS
Thromb Haemost; 1994 Feb; 71(2):164-8. PubMed ID: 8191392
[TBL] [Abstract][Full Text] [Related]
20. Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1.
Hamad OA; Nilsson PH; Wouters D; Lambris JD; Ekdahl KN; Nilsson B
J Immunol; 2010 Mar; 184(5):2686-92. PubMed ID: 20139276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
